Patent details
EP4217062
Title:
CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS
Basic Information
- Publication number:
- EP4217062
- PCT Application Number:
- EP2021075959
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP217825108
- PCT Publication Number:
- WO2022063784
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CYCLOBUTYL AMIDE MONOACYLGLYCEROL LIPASE MODULATORS
- French Title of Invention:
- MODULATEURS DE LA MONOACYLGLYCÉROL LIPASE DE CYCLOBUTYLAMIDE
- German Title of Invention:
- CYCLOBUTYLAMID-MONOACYLGLYCEROL-LIPASE-MODULATOREN
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/11/2024
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 04/12/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 09/10/2024
- Unitary Effect Registration Date:
- 04/12/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 21/09/2021
- Grant date:
- 09/10/2024
- EP Publication Date:
- 02/08/2023
- PCT Publication Date:
- 31/03/2022
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/10/2024
- EP B1 Publication Date:
- 09/10/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 21/09/2041
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/10/2024
-
-
- Name:
- JANSSEN Pharmaceutica NV
- Address:
- Turnhoutseweg 30, 2340 Beerse, Belgium (BE)
Inventor
1
- Name:
- LAFORTEZA, Brian Ngo
- Address:
- United States (US)
2
- Name:
- SAMANT, Andrew V.
- Address:
- United States (US)
3
- Name:
- GARCIA-REYNAGA, Pablo
- Address:
- United States (US)
4
- Name:
- AMERIKS, Michael K.
- Address:
- United States (US)
5
- Name:
- ALCAZAR, Jesus
- Address:
- Spain (ES)
6
- Name:
- BERRY, Cynthia B.
- Address:
- United States (US)
Priority
- Priority Number:
- 202063081475 P
- Priority Date:
- 22/09/2020
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61P 25/00;
A61P 27/02;
A61P 35/00;
C07D 205/12;
C07D 209/96;
C07D 221/20;
C07D 401/04;
C07D 401/06;
C07D 401/12;
C07D 403/04;
C07D 403/06;
C07D 403/12;
C07D 405/04;
C07D 413/04;
C07D 471/04;
A61K 31/397;
A61K 31/403;
A61K 31/438;
Publication
European Patent Bulletin
1
- Issue number:
- 202441
- Publication date:
- 09/10/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202451
- Publication date:
- 18/12/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202502
- Publication date:
- 08/01/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |